IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Translational Neurodegeneration- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

8.86

h-Index

 45

Rank

 1426

SJR

 1.849

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Translational Neurodegeneration
Abbreviation Transl. Neurodegener.
Publication Type Journal
Subject Area, Categories, Scope Cellular and Molecular Neuroscience (Q1); Cognitive Neuroscience (Q1); Neurology (clinical) (Q1)
h-index 45
Overall Rank/Ranking 1426
SCImago Journal Rank (SJR) 1.849
Impact Score 8.86
Publisher BioMed Central Ltd.
Country United Kingdom
ISSN 20479158




About Translational Neurodegeneration


Translational Neurodegeneration is a journal covering the technologies/fields/categories related to Cellular and Molecular Neuroscience (Q1); Cognitive Neuroscience (Q1); Neurology (clinical) (Q1). It is published by BioMed Central Ltd.. The overall rank of Translational Neurodegeneration is 1426. According to SCImago Journal Rank (SJR), this journal is ranked 1.849. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 45. The best quartile for this journal is Q1.

The ISSN of Translational Neurodegeneration journal is 20479158. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Translational Neurodegeneration is cited by a total of 978 articles during the last 3 years (Preceding 2021).


Translational Neurodegeneration Impact Score 2021-2022


The impact score (IS) 2021 of Translational Neurodegeneration is 8.86, which is computed in 2022 as per its definition. Translational Neurodegeneration IS is increased by a factor of 1.2 and approximate percentage change is 15.67% when compared to preceding year 2020, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Translational Neurodegeneration Impact Score 2022 Prediction


IS 2021 of Translational Neurodegeneration is 8.86. If the same upward trend persists, impact score may rise in 2022 as well.


Impact Score Trend


Year wise Impact Score (IS) of Translational Neurodegeneration. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 8.86
2020 7.66
2019 5.99
2018 5.84
2017 5.94
2016 4.67
2015 3.17
2014 4.11

Translational Neurodegeneration h-index


  Table Setting

Translational Neurodegeneration has an h-index of 45. It means 45 articles of this journal have more than 45 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Translational Neurodegeneration ISSN


The ISSN of Translational Neurodegeneration is 20479158. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Translational Neurodegeneration Rank and SCImago Journal Rank (SJR)


The overall rank of Translational Neurodegeneration is 1426. According to SCImago Journal Rank (SJR), this journal is ranked 1.849. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Translational Neurodegeneration Publisher


Table Setting

Translational Neurodegeneration is published by BioMed Central Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2012-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Translational Neurodegeneration is Transl. Neurodegener.. This abbreviation ('Transl. Neurodegener.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Translational Neurodegeneration


If your research field is/are related to Cellular and Molecular Neuroscience (Q1); Cognitive Neuroscience (Q1); Neurology (clinical) (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Biologicheskie Membrany journal 23994 Russian Academy of Sciences 11 0.17
American Journal of Physiology - Gastrointestinal and Liver Physiology journal 2397 American Physiological Society 177 4.80
Journal of Accounting, Auditing and Finance journal 6429 SAGE Publications Inc. 54 1.82
Cement and Concrete Research journal 227 Elsevier Ltd. 239 11.18
Food Research journal 17102 10 1.00
European Journal of Taxonomy journal 8868 Museum National d'Histoire Naturelle 19 1.28
Philological Encounters journal 19746 Brill Academic Publishers 2 0.41
Current Pediatric Reviews journal 8435 Bentham Science Publishers B.V. 24 3.36
Solid State Ionics journal 5964 Elsevier 201 3.42
New German Critique journal 20220 Duke University Press 15 0.14

Check complete list




Year wise Impact Score (IS) of Translational Neurodegeneration

Impact Score Table

Year Impact Score (IS)
2022/2023 Coming Soon
2021 8.86
2020 7.66
2019 5.99
2018 5.84
2017 5.94
2016 4.67
2015 3.17
2014 4.11



Top Journals/Conferences in Cellular and Molecular Neuroscience

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Alzheimer's and Dementia
Elsevier Inc. | United States

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Molecular Psychiatry
Nature Publishing Group | United Kingdom

Acta neuropathologica communications
BioMed Central Ltd. | United Kingdom

npj Parkinson's Disease
Springer Nature | United States

GLIA
John Wiley and Sons Inc. | United States

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

Cerebral Cortex
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Cognitive Neuroscience

Trends in Cognitive Sciences
Elsevier Ltd. | United Kingdom

Neuroscience and Biobehavioral Reviews
Elsevier Ltd. | United Kingdom

NeuroImage
Academic Press Inc. | United States

Alzheimer's Research and Therapy
BioMed Central Ltd. | United Kingdom

Developmental Science
Wiley-Blackwell Publishing Ltd | United Kingdom

Cerebral Cortex
Oxford University Press | United Kingdom

Developmental Cognitive Neuroscience
Elsevier BV | Netherlands

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Elsevier Inc. | United States

Social Cognitive and Affective Neuroscience
Oxford University Press | United Kingdom

Current Opinion in Behavioral Sciences
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Lancet Publishing Group | United Kingdom

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Alzheimer's and Dementia
Elsevier Inc. | United States

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley and Sons Inc. | United States

Sleep Medicine Reviews
Elsevier BV | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

See All